Literature DB >> 10926295

Evidence of a role for local complement expression in a murine model of progressive glomerulonephritis.

T R Welch1, M Frenzke, D Witte.   

Abstract

C57/B6 mice received intraperitoneal horse spleen apoferritin (4 mg) with lipopolysaccharide (0.05 mg); control mice received 0.15 M NaCl. Control and treated animals were killed weekly for 6 wk; blood and urine specimens were obtained, and tissue samples were secured. Treated animals showed evidence of significant chronic disease, with proteinuria, hematuria, and uremia. A mild glomerulonephritis was present at 2 wk, with significant proliferative glomerulonephritis at 4 wk, progressing to chronic disease with tubulointerstitial changes at 6 wk. Changes at each time period were uniform between animals. C3 mRNA was first detected by in situ hybridization at 3 wk. Message was restricted to proximal tubular and periglomerular epithelial cells. Presence of C3 message preceded the development of interstitial inflammation and fibrosis by 1-2 wk, and its location and intensity paralleled the evolving interstitial disease. Although extensive mesangial C3 protein deposits appeared early, there was never C3 message in glomeruli or infiltrating cells. Before C3 message became apparent, two cytokines known to up-regulate C3 transcription in vitro, IL-1 and IL-6, were detected by immunohistochemistry. The temporal sequence in this model is consistent with our hypothesis that local synthesis and activation of C3 in tubular epithelium is important to the interstitial component of chronic glomerulonephritis. The process is independent of the deposition of circulating complement in the glomerulus, but may be triggered by glomerular cytokines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926295     DOI: 10.1203/00006450-200008000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  The lupus-derived anti-double-stranded DNA IgG contributes to myofibroblast-like phenotype in mesangial cells.

Authors:  Yi Zhang; Jiabin Yang; Shan Jiang; Chunhong Fang; Layuan Xiong; Hong Cheng; Yumin Xia
Journal:  J Clin Immunol       Date:  2012-06-24       Impact factor: 8.317

Review 2.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

3.  Shift of C3 deposition from localization in the glomerulus into the tubulo-interstitial compartment in the absence of secreted IgM in immune complex glomerulonephritis.

Authors:  C Vaculik; B M Rüger; G Yanagida; D Hollemann; A Soleiman; U M Losert; J Chen; M B Fischer
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

4.  C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis.

Authors:  T R Welch; M Frenzke; D Witte; A E Davis
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

5.  The predictive value of peritubular capillaries C3d deposition in IgA glomerulonephritis.

Authors:  Mihaela Gherghiceanu; M Penescu; E Mandache
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

6.  Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury.

Authors:  Xiufen Zheng; Xusheng Zhang; Biao Feng; Hongtao Sun; Motohiko Suzuki; Thomas Ichim; Norihiko Kubo; Arthur Wong; Lisa R Min; Marianne E Budohn; Bertha Garcia; Anthony M Jevnikar; Wei-Ping Min
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

7.  Immune complex glomerulonephritis following bone marrow transplantation in C3 deficient mice.

Authors:  Thomas R Welch; Lisa W Blystone
Journal:  PLoS One       Date:  2008-10-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.